Activation of the DNA Damage Response by RNA Viruses |
|
Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection |
|
Animal models for COVID-19 |
|
Anti-viral immune response in the semen of cynomolgus macaques and inhibition of cell to cell transmission by broadly neutralizing antibodies in an SIV/SHIV model of infection |
|
The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression |
|
Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus |
|
Bordetella pertussis infection study in a non-human primate model of whooping cough : in vivo imaging contribution. |
|
C-type lectin-like receptor LOX-1 promotes dendritic cell-mediated class-switched B cell responses |
|
Candidature à l'Habilitation à diriger des recherches |
|
Cell-associated HIV mucosal transmission: the neglected pathway |
|
Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages |
|
Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia |
|
Cinétique des effecteurs immunologiques impliqués dans la protection contre le virus Herpès simplex type 1 (HSV1) après primo-infection par une autre souche non neurovirulente : vers un modèle vaccinal |
|
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models |
|
DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm |
|
Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo |
|
Dendritic cell- based HIV therapeutic vaccine : a study in cynomolgus macaques. |
|
Development of a DNA vaccine against the Porcine Reproductive and Respiratory Virus (PRRSV). |
|
Développement d'un vaccin à ADN contre le virus du Syndrome Dysgénésique et Respiratoire Porcin (PRRSV) |
|
Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from Mauritius Island. |
|
Dynamic of the establisment of HSV1's latency and reactivation. |
|
Dynamique des cellules dendritiques et d'agents de l'immuno-suppression au cours de l'infection primaire du macaque par le virus de l'immunodéficience simienne : relations temporelles avec les paramètres biologiques de progession vers la maladie |
|
Dynamique des réponses lymphocytaires T locales et systémiques à l'injection d'un vaccin dans la peau |
|
Early cellular and molecular changings and the injection site of vaccines : Caracterization of the innate and adaptive immune response after a recombining MVA injection. |
|
Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV infected patients. |
|
Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera |
|
Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients |
|
Étude de l'effet de l'expression de la protéine virale Nef du virus de l'immunodéficience humaine sur la lymphopoïèse T |
|
Etude des activités antivirales solubles non cytolytiques des lymphocytes CD8+ au cours de l'infection par SIV : Effet d'un traitement par polychimiothérapie post-exposition, effet d'un traitement immuno-modulateur par l'interleukine 2 et mécanismes de reconstitution lymphocytaire T CD4+ |
|
Etude du contrôle de l'etablissement de l'infection latente de HSV1 et de sa capacité de réactivation |
|
Etude du rôle des cellules infectées dans la transmission par voie sexuelle du VIH et étude de molécules à visée microbicide : approche dans le modèle de l'infection expérimentale par les SHIV162MfP5/SIVMAC251 chez le macaque cynomolgus |
|
Etudes des mécanismes associés à la qualité et la durabilité de la réponse vaccinale |
|
Evaluation de l'efficacité et l'innocuité de différentes stratégies de thérapie génique de l'infection par le VIH basées sur l'expression faible et constitutive de l'interféron beta : approche dans le modèle de l'infection expérimentale du macaque par un isolat primaire et pathogène du SIVmac251 |
|
Evaluation of the effectivennes and the harmlessness of various strategies of genic therapy of the infection by the HIV based on the expression weak and constitutive of the interferon beta. |
|
Evaluation préclinique d'un protocole vaccinal anti-VIH utilisant des pseudo-particules rétrovirales recombinantes administrées par voies muqueuses et étude des mécanismes immunologiques associés |
|
Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation |
|
Gene therapy strategy to reduced bone marrow aplasia : evaluation in cynomolgus macaque exposed to a gamma total body irradiation. |
|
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates |
|
Immune response dynamic after vaccination : in vivo imaging in non human primate model. |
|
Impact d'un traitement antirétroviral conventionnel sur la transmission, la dissémination et la réplication virale dans le modèle du macaque infecté par SIV |
|
Impact of short-term HAART initiated during the chronic stage or shortly post-exposure on SIV infection of male genital organs |
|
In silico definition of HIV-1 epitopes inducing a CTL response according to the viral variability and patients’ immunogenetics. |
|
In vivo imaging in NHP models of malaria: challenges, progress and outlooks |
|
In vivo imaging of the local immune response to intradermal vaccination with a plasmid DNA associated to skin electroporation in cynomolgus monkeys. |
|
Infection of macaques with simian or human lentiviruses application to the evaluation of vaccine strategies against human immunodeficiency virus inection. |
|
Infection of semen-producing organs by SIV during the acute and chronic stages of the disease |
|
Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection |
|
Innate Molecular and Cellular Signature in the Skin Preceding Long-Lasting T Cell Responses after Electroporated DNA Vaccination |
|
Kinetics of immune effectors involved in protection against HSV1 after a primary infection by a non-virulent strain : toward a vaccinal model. |
|
L'initiation précoce du traitement antirétroviral conserve la fonction immunitaire dans l'intestin de patients infectés par le VIH |
|
Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses |
|
Low autocrine interferon beta production as a gene therapy approach for AIDS: Infusion of interferon beta-engineered lymphocytes in macaques chronically infected with SIVmac251 |
|
Macrophage- and neutrophil-derived TNF-α instructs skin langerhans cells to prime antiviral immune responses |
|
MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaques |
|
Modulation of DNA damage and repair pathways by human tumour viruses |
|
Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection |
|
Nouveaux pseudotypes rétroviraux basés sur les glycoprotéines d'enveloppe de paramyxovirus : applications biothérapeutiques en thérapie génique et en vaccinologie |
|
Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice |
|
Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus Macaques |
|
Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection. |
|
Plasmacytoid dendritic cell dynamics tune interferon-alfa production in SIV-infected cynomolgus macaques |
|
Prime-boost immunization strategies against Chikungunya virus |
|
Proceedings of the Frontiers of Retrovirology Conference 2016. |
|
Reconnaissance de variants d'un épitope viral par des lymphocytes T CD8+ induits par la vaccination de singes rhésus |
|
Regulated Expression of Sodium‐dependent Glutamate Transporters and Synthetase: a Neuroprotective Role for Activated Microglia and Macrophages in HIV Infection? |
|
RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation |
|
Role of semen infected leukocytes in HIV mucosal transmission : Experimental model of SIVmac251 infection in Macaca fascicularis |
|
Semen CD4+ T cells and macrophages are productively infected at all stages of SIV infection in macaques |
|
SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activity |
|
Study of quality and durability of vaccine immune response associated mechanisms. |
|
Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC+ CD4+ cell levels: a surrogate marker candidate of HIV-induced intestinal damage. |
|
Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells |
|
Therapeutic activity and mode of action of a novel virotherapy to restore sepsis-induced immunosuppression |
|
Thermosensitive and mucoadhesive pluronic-hydroxypropylmethylcellulose hydrogel containing the mini-CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervicovaginal mucus |
|
Tissue-specific B-cell dysfunction and generalized memory B-cell loss during acute SIV infection |
|
Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery |
|
Transfert de gène dans les cellules médullaires CD34+ : étude chez le macaque cynomolgus de la reconstitution des lignées lymphoïdes et myéloïdes après irradiation gamma |
|
Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development |
|
Utilisation de cellules dendritiques en vaccination thérapeutique anti-VIH : approche expérimentale chez le macaque |
|
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates |
|